Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

An Artificial Intelligence Assisted Telehealth Intervention to Promote Self-Management in Patients With Type 2 Diabetes Mellitus (Qualitative Interview)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03868813
Recruitment Status : Completed
First Posted : March 11, 2019
Last Update Posted : September 24, 2021
Sponsor:
Information provided by (Responsible Party):
Mohanraj Thirumalai, University of Alabama at Birmingham

Brief Summary:
This protocol involves a qualitative study of the needs/preferences of people with diabetes and health coaches regarding a telehealth coaching platform for glycemic control in people with diabetes.

Condition or disease Intervention/treatment
Diabetes Mellitus Behavioral: Semi-structured Interview

Layout table for study information
Study Type : Observational
Actual Enrollment : 20 participants
Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: An Artificial Intelligence Assisted Telehealth Intervention to Promote Self-Management in Patients With Type 2 Diabetes Mellitus (Qualitative Interview)
Actual Study Start Date : July 1, 2019
Actual Primary Completion Date : July 1, 2021
Actual Study Completion Date : July 1, 2021

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Telehealth

Group/Cohort Intervention/treatment
Interview with People with Diabetes
One-on-One interview with people with diabetes
Behavioral: Semi-structured Interview
One-on-one semi-structured interviews

Interview with Health Coaches
One-on-One interview with health coaches
Behavioral: Semi-structured Interview
One-on-one semi-structured interviews




Primary Outcome Measures :
  1. Users' Expectation from a Health Coaching System [ Time Frame: 60 minutes ]
    This interview with participants help produce knowledge on the users' expectations from a health coaching system



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
There will be a total of two 2 groups - one group comprising of 10 health experts and another group 2comprising of 10 patient/caregiver dyads (20 people). There is no treatment or intervention offered, only the interview questionnaire will differ based on the group.
Criteria

Inclusion Criteria:

Health Coaches Group:

(i) age between 18 and 80 years (ii) fluent in English (iii) work in or carry expertise in physical activity, nutrition/diet or health behavior.

People with Diabetes Group (Patient/Caregiver Dyads):

(i) age between 18 and 80 years (ii) fluent in English (iii) have Type-II diabetes.

Exclusion Criteria:

None


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03868813


Locations
Layout table for location information
United States, Alabama
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35294
Sponsors and Collaborators
University of Alabama at Birmingham
Layout table for additonal information
Responsible Party: Mohanraj Thirumalai, Assistant Professor, University of Alabama at Birmingham
ClinicalTrials.gov Identifier: NCT03868813    
Other Study ID Numbers: UAB-DRC-2019-1
First Posted: March 11, 2019    Key Record Dates
Last Update Posted: September 24, 2021
Last Verified: September 2021

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Diabetes Mellitus
Diabetes Mellitus, Type 2
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases